In recent years, evidences support that MSC-derived EVs play therapeutic roles in several kinds of liver damage induced by CCL4 [29], D-GalN/LPS [30], hepatic ischemia reperfusion [31], and hepatic S100 [32]. The gene discussed is CCL4; the disease is ischemia.